Danaher Corporation · DHR · Next earnings

Danaher Corporation reports Wednesday, Jan 27, 2027

DHR reports before market open with consensus EPS at $2.49 and revenue at $7.49B. Last quarter: Danaher Raises EPS Guidance as Q3 Core Growth Reaches 5.5%

Reports Before market open83 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.49 Calendar consensus
Consensus revenue $7.49B Calendar consensus
Report date Jan 27, 2027 Wednesday, date estimated
Session Before market open 83 days away

Where DHR left off: FY2026 Q3

Full report

Danaher Raises EPS Guidance as Q3 Core Growth Reaches 5.5%

EPS surprise +9.9% Reported $2.11 vs $1.92
Revenue surprise -0.1% Reported $6.55B vs $6.56B
Stock move +4.3% Event window
Subsequent drift 0.0% Up to 20 sessions

Full-year adjusted diluted EPS guidance was raised to $8.57–$8.62; management also targeted 4–5% ex-respiratory core revenue growth for fiscal 2027.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Respiratory revenue volatility tied to flu-season and pandemic dynamics.
  • Academic demand remains below historic levels.
  • Integration and execution risk for Masimo, StatLab, and AI initiatives.
  • The 4–5% fiscal 2027 ex-respiratory growth target may remain modest if recovery is uneven.

Questions analysts left open

  • Why fiscal 2027 core growth guidance remains modest at 4–5% despite improving markets.
  • Sustainability of bioprocessing growth and the outlook for respiratory revenue.
  • Execution and integration risk from recent acquisitions and AI initiatives.

Ask FN2 about DHR next report

Transcript, numbers and history already loaded
What should I watch for in DHR's next earnings report?How did DHR guide last quarter, and is consensus above or below that?Give me the bull and bear case going into DHR earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the DHR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent DHR quarters

All DHR earnings
+4.3%FY2026 Q3-11.0%FY2026 Q2-0.5%FY2026 Q1-4.8%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.